Vesicoureteral reflux: From prophylaxis to surgery

被引：17
|
作者：
Blais, Anne-Sophie [1 ]
Bolduc, Stephane [1 ,2 ,3 ]
Moore, Katherine [1 ]
机构：
[1] Univ Laval, CHU Quebec, Div Urol, Quebec City, PQ, Canada
[2] Univ Laval, CRCHU Quebec, Quebec City, PQ, Canada
[3] Axe Med Regeneratrice, Quebec City, PQ, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2017年 / 11卷 / 1-2期
关键词：
DEXTRANOMER HYALURONIC-ACID; ENDOSCOPIC TREATMENT; RISK-FACTORS; CHILDREN; INJECTION; POLYDIMETHYLSILOXANE; EFFICACY; BLADDER;
D O I：
10.5489/cuaj.4342
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Vesicoureteral reflux (VUR) is one of the most common pathologies encountered in pediatric urology. Better understanding of the evolution of VUR and new endoscopic surgical techniques in the last decades have led to major changes in the management of this pathology. However, the treatment algorithm remains complex and is composed of a wide variety of options, from active surveillance to surgical treatment. Herein, we propose to review treatment options for VUR in order to help clinicians make the right treatment decision for the right patient.
引用
收藏
页码：13 / 18
页数：6
相关论文
共 50 条
12345